{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:54:16Z","timestamp":1793328856360,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Erasmus MC Foundation","award":["Daniel den Hoed Award 2021"],"award-info":[{"award-number":["Daniel den Hoed Award 2021"]}]},{"name":"Stichting Semmy","award":["Stichting Semmy"],"award-info":[{"award-number":["Stichting Semmy"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-026-01458-0","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:33:55Z","timestamp":1780058035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reconstruction matters: influence of EARL standards and BSREM in [18F]FET PET for distinguishing glioma progression from treatment-related changes"],"prefix":"10.1186","volume":"16","author":[{"given":"J.","family":"de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Segbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Harteveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. J.","family":"Bron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Valkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E. M.","family":"Veldhuijzen van Zanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"1458_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.hoc.2021.08.012","volume":"36","author":"SS Francis","year":"2022","unstructured":"Francis SS, Ostrom QT, Cote DJ, Smith TR, Claus E, Barnholtz-Sloan JS. The Epidemiology of Central Nervous System Tumors. Hematol Oncol Clin North Am. 2022;36:23\u201342.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1458_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"1458_CR3","first-page":"512","volume":"4","author":"J Kopecka","year":"2021","unstructured":"Kopecka J, Riganti C. Overcoming drug resistance in glioblastoma: new options in sight? Cancer Drug Resist. 2021;4:512\u20136.","journal-title":"Cancer Drug Resist"},{"key":"1458_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","volume":"64","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64:479\u201389.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1458_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/cncr.23562","volume":"113","author":"W Taal","year":"2008","unstructured":"Taal W, Brandsma D, de Bruin HG, Bromberg JE, Swaak-Kragten AT, Smitt PA, et al. Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. Cancer. 2008;113:405\u201310.","journal-title":"Cancer"},{"key":"1458_CR6","doi-asserted-by":"crossref","unstructured":"Fu R, Szidonya L, Barajas RF Jr., Ambady P, Varallyay C, Neuwelt EA. Diagnostic performance of DSC perfusion MRI to distinguish tumor progression and treatment-related changes: a systematic review and meta-analysis. Neurooncol Adv. 2022;4:vdac027.","DOI":"10.1093\/noajnl\/vdac027"},{"key":"1458_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/CCO.0000000000000793","volume":"33","author":"L Nichelli","year":"2021","unstructured":"Nichelli L, Casagranda S. Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis. Curr Opin Oncol. 2021;33:597\u2013607.","journal-title":"Curr Opin Oncol"},{"key":"1458_CR8","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/S1470-2045(23)00525-9","volume":"25","author":"NL Albert","year":"2024","unstructured":"Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, et al. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group. Lancet Oncol. 2024;25:e29-41.","journal-title":"Lancet Oncol"},{"key":"1458_CR9","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1007\/s00259-025-07366-0","volume":"52","author":"MJ Mair","year":"2025","unstructured":"Mair MJ, Lohmann P, Galldiks N, Belting M, Brandal P, Broen MPG, et al. Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey. Eur J Nucl Med Mol Imaging. 2025;52:4627\u201338.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"1458_CR10","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2967\/jnumed.108.057182","volume":"50","author":"R Boellaard","year":"2009","unstructured":"Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009;50(Suppl 1):S11-20.","journal-title":"J Nucl Med"},{"issue":"1","key":"1458_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13550-017-0316-x","volume":"7","author":"CP Filss","year":"2017","unstructured":"Filss CP, Albert NL, Boning G, Kops ER, Suchorska B, Stoffels G, et al. O-(2-[(18)F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres. EJNMMI Res. 2017;7:64.","journal-title":"EJNMMI Res"},{"key":"1458_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1458_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","volume":"37","author":"R Boellaard","year":"2010","unstructured":"Boellaard R, O\u2019Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181\u2013200.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1458_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40658-018-0223-x","volume":"5","author":"M Messerli","year":"2018","unstructured":"Messerli M, Stolzmann P, Egger-Sigg M, Trinckauf J, D\u2019Aguanno S, Burger IA, et al. Impact of a Bayesian penalized likelihood reconstruction algorithm on image quality in novel digital PET\/CT: clinical implications for the assessment of lung tumors. EJNMMI Phys. 2018;5:27.","journal-title":"EJNMMI Phys"},{"key":"1458_CR15","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/neuonc\/nov225.24","volume":"17","author":"BM Ellingson","year":"2015","unstructured":"Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, et al. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro Oncol. 2015;17:1188\u201398.","journal-title":"Neuro Oncol"},{"key":"1458_CR16","doi-asserted-by":"crossref","unstructured":"Beare R, Lowekamp B, Yaniv Z. Image Segmentation, Registration and Characterization in R with SimpleITK. J Stat Softw. 2018;86:1-35 .","DOI":"10.18637\/jss.v086.i08"},{"key":"1458_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fninf.2013.00045","volume":"7","author":"BC Lowekamp","year":"2013","unstructured":"Lowekamp BC, Chen DT, Ibanez L, Blezek D. The Design of SimpleITK. Front Neuroinform. 2013;7:45.","journal-title":"Front Neuroinform"},{"key":"1458_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s10278-017-0037-8","volume":"31","author":"Z Yaniv","year":"2018","unstructured":"Yaniv Z, Lowekamp BC, Johnson HJ, Beare R. SimpleITK Image-Analysis Notebooks: a Collaborative Environment for Education and Reproducible Research. J Digit Imaging. 2018;31:290\u2013303.","journal-title":"J Digit Imaging"},{"key":"1458_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13550-017-0295-y","volume":"7","author":"M Unterrainer","year":"2017","unstructured":"Unterrainer M, Vettermann F, Brendel M, Holzgreve A, Lifschitz M, Zahringer M, et al. Towards standardization of (18)F-FET PET imaging: do we need a consistent method of background activity assessment? EJNMMI Res. 2017;7:48.","journal-title":"EJNMMI Res"},{"key":"1458_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00259-018-4207-9","volume":"46","author":"I Law","year":"2019","unstructured":"Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, et al. Joint EANM\/EANO\/RANO practice guidelines\/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2019;46:540\u201357.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1458_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10278-021-00570-y","volume":"35","author":"V Liberini","year":"2022","unstructured":"Liberini V, Pizzuto DA, Messerli M, Orita E, Grunig H, Maurer A, et al. BSREM for brain metastasis detection with 18F-FDG-PET\/CT in lung cancer patients. J Digit Imaging. 2022;35:581\u201393.","journal-title":"J Digit Imaging"},{"key":"1458_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13550-019-0536-3","volume":"9","author":"J Ly","year":"2019","unstructured":"Ly J, Minarik D, Edenbrandt L, Wollmer P, Tragardh E. The use of a proposed updated EARL harmonization of (18)F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations. EJNMMI Res. 2019;9:65.","journal-title":"EJNMMI Res"},{"key":"1458_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-020-00690-6","volume":"10","author":"M Wyrzykowski","year":"2020","unstructured":"Wyrzykowski M, Siminiak N, Kazmierczak M, Ruchala M, Czepczynski R. Impact of the Q.Clear reconstruction algorithm on the interpretation of PET\/CT images in patients with lymphoma. EJNMMI Res. 2020;10:99.","journal-title":"EJNMMI Res"},{"key":"1458_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s13139-019-00594-x","volume":"53","author":"A Matti","year":"2019","unstructured":"Matti A, Lima GM, Pettinato C, Pietrobon F, Martinelli F, Fanti S. How Do the More Recent Reconstruction Algorithms Affect the Interpretation Criteria of PET\/CT Images? Nucl Med Mol Imaging. 2019;53:216\u201322.","journal-title":"Nucl Med Mol Imaging"},{"key":"1458_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-023-01042-w","volume":"13","author":"MC Cox","year":"2023","unstructured":"Cox MC, Jurcka T, Arens AIJ, van Rijk MC, Kaanders J, van den Bosch S. Quantitative and clinical implications of the EARL2 versus EARL1 [(18)F]FDG PET-CT performance standards in head and neck squamous cell carcinoma. EJNMMI Res. 2023;13:91.","journal-title":"EJNMMI Res"},{"key":"1458_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-071327","volume":"13","author":"ES Koh","year":"2023","unstructured":"Koh ES, Gan HK, Senko C, Francis RJ, Ebert M, Lee ST, et al. [(18)F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: Protocol for a prospective, multicentre PET\/CT trial. BMJ Open. 2023;13:e071327.","journal-title":"BMJ Open"},{"key":"1458_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11060-021-03844-1","volume":"155","author":"J Ort","year":"2021","unstructured":"Ort J, Hamou HA, Kernbach JM, Hakvoort K, Blume C, Lohmann P, et al. (18)F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III\/IV glioma: Moving towards a multimodal imaging-guided resection. J Neurooncol. 2021;155:71\u201380.","journal-title":"J Neurooncol"},{"key":"1458_CR28","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.21037\/qims-22-1340","volume":"13","author":"ZQ Ouyang","year":"2023","unstructured":"Ouyang ZQ, Zheng GR, Duan XR, Zhang XR, Ke TF, Bao SS, et al. Diagnostic accuracy of glioma pseudoprogression identification with positron emission tomography imaging: A systematic review and meta-analysis. Quant Imaging Med Surg. 2023;13:4943\u201359.","journal-title":"Quant Imaging Med Surg"},{"key":"1458_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092631","author":"D Henssen","year":"2023","unstructured":"Henssen D, Leijten L, Meijer FJA, van der Kolk A, Arens AIJ, Ter Laan M, et al. Head-to-head comparison of PET and perfusion weighted MRI techniques to distinguish treatment related abnormalities from tumor progression in glioma. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15092631.","journal-title":"Cancers (Basel)."},{"key":"1458_CR30","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"1458_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2967\/jnumed.124.268768","volume":"66","author":"KJ Langen","year":"2025","unstructured":"Langen KJ, Stoffels G, Filss CP, Kocher M, Lerche C, Sabel M, et al. Borderline findings in O-(2-[(18)F]-Fluoroethyl)-l-Tyrosine PET of patients with suspected glioma relapse: Role in clinical practice. J Nucl Med. 2025;66:187\u201393.","journal-title":"J Nucl Med"},{"key":"1458_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11060-015-1774-5","volume":"123","author":"I Melguizo-Gavilanes","year":"2015","unstructured":"Melguizo-Gavilanes I, Bruner JM, Guha-Thakurta N, Hess KR, Puduvalli VK. Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard? J Neurooncol. 2015;123:141\u201350.","journal-title":"J Neurooncol"},{"key":"1458_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-023-00588-x","volume":"10","author":"M Shekari","year":"2023","unstructured":"Shekari M, Verwer EE, Yaqub M, Daamen M, Buckley C, Frisoni GB, et al. Harmonization of brain PET images in multi-center PET studies using Hoffman phantom scan. EJNMMI Phys. 2023;10:68.","journal-title":"EJNMMI Phys"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-026-01458-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01458-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01458-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:03:58Z","timestamp":1785521038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-026-01458-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1458"],"URL":"https:\/\/doi.org\/10.1186\/s13550-026-01458-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8763716\/v1","asserted-by":"object"}]},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the local ethics committee of Erasmus Medical Centre, Rotterdam. Written informed consent was obtained from all participants prior to inclusion in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JDJ, MS, AAH, WJB, RV, RB and SEMVZ declare they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"118"}}